Investor Presentaiton

Solid organic growth of 8% in 9M 2022/23 with continued good momentum across business areas and geographies 9M 2022/23 revenue by business area 9M 2022/23 revenue by geography Business area Ostomy Care Continence Care Reported revenue DKKm Organic growth Share of organic growth Geographic area 6,724 7% 37% European markets 7% 32% 5,944 Reported revenue DKKm Organic growth Share of organic growth 10,404 5% 40% Voice & 9% 5% Respiratory Care* 1,450 Other developed markets 4,757 10% 32% Wound & Skin 2,125 6% 10% Care Emerging markets 3,113 12% 28% Interventional 2,031 11% 16% Urology Coloplast Group * Part of organic growth since February 1, 2023 61 18,274 8% 100% Coloplast Group 18,274 8% 100% Coloplast

View entire presentation